Works matching DE "ECULIZUMAB"

Results: 818

Hypertensive Emergency and Atypical Hemolytic Uremic Syndrome Associated with Cocaine Use: A Diagnostic and Therapeutic Challenge.

Published in:

2025

By:

Jiménez Mayor, Elena;
De La Flor, José C.;
Rocha Rodrigues, André;
Rodríguez Tudero, Celia;
Zamora González-Mariño, Rocío;
Apaza, Jacqueline;
Moral Berrio, Esperanza;
Deira Lorenzo, Javier

Publication type:

Case Study

Acetylcholine‐sensitive control of long‐term synaptic potentiation in hippocampal CA3 neurons.

Published in:

Hippocampus, 2023, v. 33, n. 8, p. 948, doi. 10.1002/hipo.23533

By:

Kassab, Randa

Publication type:

Article

Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 10, p. 919, doi. 10.3390/jcm8070919

By:

Gonzalez Suarez, Maria L.;
Thongprayoon, Charat;
Mao, Michael A.;
Leeaphorn, Napat;
Bathini, Tarun;
Cheungpasitporn, Wisit

Publication type:

Article

Outcomes of Kidney Transplant Patients with Atypical Hemolytic Uremic Syndrome Treated with Eculizumab: A Systematic Review and Meta-Analysis.

Published in:

Journal of Clinical Medicine, 2019, v. 8, n. 7, p. 919, doi. 10.3390/jcm8070919

By:

Gonzalez Suarez, Maria L.;
Thongprayoon, Charat;
Mao, Michael A.;
Leeaphorn, Napat;
Bathini, Tarun;
Cheungpasitporn, Wisit

Publication type:

Article

The Extended Use of Eculizumab in Pregnancy and Complement Activation–Associated Diseases Affecting Maternal, Fetal and Neonatal Kidneys—The Future Is Now?

Published in:

Journal of Clinical Medicine, 2019, p. 407, doi. 10.3390/jcm8030407

By:

Stefanovic, Vedran

Publication type:

Article

Speaker Abstracts.

Published in:: Basic & Clinical Pharmacology & Toxicology, 2013, v. 113, p. 4, doi. 10.1111/bcpt.12127
Publication type:: Article

Influence of tranexamic acid on the complement system in trauma.

Published in:

ANZ Journal of Surgery, 2020, v. 90, n. 4, p. 418, doi. 10.1111/ans.15538

By:

Barrett, Christopher D.;
Yaffe, Michael B.

Publication type:

Article

Real‐world experience with eculizumab and switching to ravulizumab for generalized myasthenia gravis.

Published in:

Annals of Clinical & Translational Neurology, 2024, v. 11, n. 5, p. 1338, doi. 10.1002/acn3.52051

By:

Tokuyasu, Daiki;
Suzuki, Shigeaki;
Uzawa, Akiyuki;
Nagane, Yuriko;
Masuda, Masayuki;
Konno, Shingo;
Kubota, Tomoya;
Samukawa, Makoto;
Sugimoto, Takamichi;
Ishizuchi, Kei;
Oyama, Munenori;
Yasuda, Manato;
Akamine, Hiroyuki;
Onishi, Yosuke;
Suzuki, Yasushi;
Kawaguchi, Naoki;
Minami, Naoya;
Kimura, Takashi;
Takahashi, Masanori P.;
Murai, Hiroyuki

Publication type:

Article

Long‐term efficacy of eculizumab in refractory generalized myasthenia gravis: responder analyses.

Published in:

Annals of Clinical & Translational Neurology, 2021, v. 8, n. 7, p. 1398, doi. 10.1002/acn3.51376

By:

Howard, James F.;
Karam, Chafic;
Yountz, Marcus;
O'Brien, Fanny L.;
Mozaffar, Tahseen

Publication type:

Article

Autoantibodies against complement component C1q in systemic lupus erythematosus.

Published in:

Clinical & Translational Immunology, 2021, v. 10, n. 4, p. 1, doi. 10.1002/cti2.1279

By:

Trendelenburg, Marten

Publication type:

Article

Role of uromodulin and complement activation in the progression of kidney disease.

Published in:

Oncology Letters, 2021, v. 22, n. 6, p. N.PAG, doi. 10.3892/ol.2021.13090

By:

Shen, Fei;
Liu, Maojing;
Pei, Fei;
Yu, Li;
Yang, Xiangdong

Publication type:

Article

A novel anti-EGFR monoclonal antibody (EMab-17) exerts antitumor activity against oral squamous cell carcinomas via antibody-dependent cellular cytotoxicity and complement-dependent cytotoxicity.

Published in:

Oncology Letters, 2020, v. 19, n. 4, p. 2809, doi. 10.3892/ol.2020.11384

By:

JUNKO TAKEI;
MIKA KATO KANEKO;
TOMOKAZU OHISHI;
MANABU KAWADA;
HIROYUKI HARADA;
YUKINARI KATO

Publication type:

Article

Diagnosis of Atypical Hemolytic Uremic Syndrome and Response to Eculizumab Therapy.

Published in:

2014

By:

Nguyen, May H.;
Mathew, Jacob J.;
Denunzio, Troy M.;
Carmichael, Mark G.

Publication type:

Case Study

Combination of Ruxolitinib and Eculizumab for Treatment of Severe SARS-CoV-2-Related Acute Respiratory Distress Syndrome: A Controlled Study.

Published in:

Frontiers in Pharmacology, 2020, v. 11, p. 1, doi. 10.3389/fphar.2020.00857

By:

Giudice, Valentina;
Pagliano, Pasquale;
Vatrella, Alessandro;
Masullo, Alfonso;
Poto, Sergio;
Polverino, Benedetto Maria;
Gammaldi, Renato;
Maglio, Angelantonio;
Sellitto, Carmine;
Vitale, Carolina;
Serio, Bianca;
Cuffa, Bianca;
Borrelli, Anna;
Vecchione, Carmine;
Filippelli, Amelia;
Selleri, Carmine

Publication type:

Article

Association Study of the Complement Component C4 Gene in Tardive Dyskinesia.

Published in:

Frontiers in Pharmacology, 2019, v. 10, p. 1, doi. 10.3389/fphar.2019.01339

By:

Zai, Clement C.;
Tiwari, Arun K.;
Zai, Gwyneth C.;
Freeman, Natalie;
Pouget, Jennie G.;
Greco, James;
Tampakeras, Maria;
Shaikh, Sajid A.;
Herbert, Deanna;
Emmerson, Heather;
Cheema, Sheraz Y.;
Braganza, Nicole;
Müller, Daniel J.;
Voineskos, Aristotle N.;
Remington, Gary;
Kennedy, James L.

Publication type:

Article

Complement Receptor-Mediated Phagocytosis Induces Proinflammatory Cytokine Production in Murine Macrophages.

Published in:

Frontiers in Immunology, 2020, v. 10, p. 1, doi. 10.3389/fimmu.2019.03049

By:

Acharya, Durga;
Li, Xiao Rui (Lisa);
Heineman, Rebecca Emily-Sue;
Harrison, Rene E.

Publication type:

Article

Editorial: The Role of Pentraxins: From Inflammation, Tissue Repair and Immunity to Biomarkers.

Published in:

2019

By:

Bottazzi, Barbara;
Garlanda, Cecilia;
Teixeira, Mauro Martins

Publication type:

Editorial

Elucidating the Immune Evasion Mechanisms of Borrelia mayonii , the Causative Agent of Lyme Disease.

Published in:

Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02722

By:

Walter, Lea;
Sürth, Valerie;
Röttgerding, Florian;
Zipfel, Peter F.;
Fritz-Wolf, Karin;
Kraiczy, Peter

Publication type:

Article

Binding of von Willebrand Factor to Complement C1q Decreases the Phagocytosis of Cholesterol Crystals and Subsequent IL-1 Secretion in Macrophages.

Published in:

Frontiers in Immunology, 2019, v. 10, p. 1, doi. 10.3389/fimmu.2019.02712

By:

Donat, Claudia;
Thanei, Sophia;
Trendelenburg, Marten

Publication type:

Article

Absence of the Lectin Activation Pathway of Complement Ameliorates Proteinuria-Induced Renal Injury.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02238

By:

Alghadban, Samy;
Kenawy, Hany I.;
Dudler, Thomas;
Schwaeble, Wilhelm J.;
Brunskill, Nigel J.

Publication type:

Article

Insights Into Enhanced Complement Activation by Structures of Properdin and Its Complex With the C-Terminal Domain of C3b.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02097

By:

van den Bos, Ramon M.;
Pearce, Nicholas M.;
Granneman, Joke;
Brondijk, T. Harma C.;
Gros, Piet

Publication type:

Article

Structural Basis for Properdin Oligomerization and Convertase Stimulation in the Human Complement System.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.02007

By:

Pedersen, Dennis V.;
Gadeberg, Trine A. F.;
Thomas, Caroline;
Wang, Yong;
Joram, Nicolas;
Jensen, Rasmus K.;
Mazarakis, Sofia M. M.;
Revel, Margot;
El Sissy, Carine;
Petersen, Steen V.;
Lindorff-Larsen, Kresten;
Thiel, Steffen;
Laursen, Nick S.;
Fremeaux-Bacchi, Véronique;
Andersen, Gregers R.

Publication type:

Article

Regulation of the Complement System by Pentraxins.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01750

By:

Haapasalo, Karita;
Meri, Seppo

Publication type:

Article

Characterization of the C1q-Binding Ability and the IgG1-4 Subclass Profile of Preformed Anti-HLA Antibodies by Solid-Phase Assays.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01712

By:

Navas, Ana;
Molina, Juan;
Agüera, María-Luisa;
Guler, Ipek;
Jurado, Aurora;
Rodríguez-Benot, Alberto;
Alonso, Corona;
Solana, Rafael

Publication type:

Article

Complement Factor H Modulates Splenic B Cell Development and Limits Autoantibody Production.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01607

By:

Kiss, Máté G.;
Ozsvár-Kozma, Mária;
Porsch, Florentina;
Göderle, Laura;
Papac-Miličević, Nikolina;
Bartolini-Gritti, Barbara;
Tsiantoulas, Dimitrios;
Pickering, Matthew C.;
Binder, Christoph J.

Publication type:

Article

The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01590

By:

Eriksson, Oskar;
Mohlin, Camilla;
Nilsson, Bo;
Ekdahl, Kristina N.

Publication type:

Article

Corrigendum: Complement System Inhibition Modulates the Pro-Inflammatory Effects of a Snake Venom Metalloproteinase.

Published in:

2019

By:

Luchini, Lygia Samartin Gonçalves;
Pidde, Giselle;
Squaiella-Baptistão, Carla Cristina;
Tambourgi, Denise V.

Publication type:

Correction Notice

Complement Receptor Type 1 (CR1, CD35), the Inhibitor of BCR-Mediated Human B Cell Activation, Differentially Regulates TLR7, and TLR9 Induced Responses.

Published in:

Frontiers in Immunology, 2019, p. 1, doi. 10.3389/fimmu.2019.01493

By:

Mácsik-Valent, Bernadett;
Nagy, Katinka;
Fazekas, László;
Erdei, Anna

Publication type:

Article

Anti-complement Treatment for Paroxysmal Nocturnal Hemoglobinuria: Time for Proximal Complement Inhibition? A Position Paper From the SAAWP of the EBMT.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.01157

By:

Risitano, Antonio M.;
Marotta, Serena;
Ricci, Patrizia;
Marano, Luana;
Frieri, Camilla;
Cacace, Fabiana;
Sica, Michela;
Kulasekararaj, Austin;
Calado, Rodrigo T.;
Scheinberg, Phillip;
Notaro, Rosario;
Peffault de Latour, Regis

Publication type:

Article

The Emerging Role of Complement Proteins as a Target for Therapy of IgA Nephropathy.

Published in:

Frontiers in Immunology, 2019, p. N.PAG, doi. 10.3389/fimmu.2019.00504

By:

Rizk, Dana V.;
Maillard, Nicolas;
Julian, Bruce A.;
Knoppova, Barbora;
Green, Todd J.;
Novak, Jan;
Wyatt, Robert J.

Publication type:

Article

Apolipoprotein E in dense deposits: a parting of the ways in C3 glomerulopathy.

Published in:

Clinical Kidney Journal, 2024, v. 17, n. 6, p. 1, doi. 10.1093/ckj/sfae161

By:

Tavares, Joana;
Caravaca-Fontán, Fernando;
Praga, Manuel

Publication type:

Article

Podocyte puzzle: IgA nephropathy.

Published in:

Clinical Kidney Journal, 2023, v. 16, n. 12, p. 2760, doi. 10.1093/ckj/sfad244

By:

Bharati, Joyita;
Munir, Kiran;
Jhaveri, Kenar D

Publication type:

Article

Urinary markers of the alternative and lectin complement pathway are increased in IgA vasculitis nephritis.

Published in:

Clinical Kidney Journal, 2023, v. 16, n. 12, p. 2703, doi. 10.1093/ckj/sfad236

By:

Marro, Julien;
Chetwynd, Andrew J;
Hawkes, Jennifer;
Northey, Sarah J;
Oni, Louise

Publication type:

Article

Eculizumab discontinuation in atypical haemolytic uraemic syndrome: TMA recurrence risk and renal outcomes.

Published in:

Clinical Kidney Journal, 2021, v. 14, n. 9, p. 2075, doi. 10.1093/ckj/sfab005

By:

Ariceta, Gema;
Fakhouri, Fadi;
Sartz, Lisa;
Miller, Benjamin;
Nikolaou, Vasilis;
Cohen, David;
Siedlecki, Andrew M;
Ardissino, Gianluigi

Publication type:

Article

Outcome of atypical haemolytic uraemic syndrome relapse after eculizumab withdrawal.

Published in:

Clinical Kidney Journal, 2021, v. 14, n. 8, p. 1939, doi. 10.1093/ckj/sfaa241

By:

Duineveld, Caroline;
Bouwmeester, Romy;
Heijden, Joost W van der;
Berger, Stefan P;
Kar, Nicole C A J van de;
Wetzels, Jack F M;
Group, the Dutch aHUS Working

Publication type:

Article

Atypical hemolytic uremic syndrome in Brazil: clinical presentation, genetic findings and outcomes of a case series in adults and children treated with eculizumab.

Published in:

Clinical Kidney Journal, 2021, v. 14, n. 4, p. 1126, doi. 10.1093/ckj/sfaa062

By:

Palma, Lilian Monteiro Pereira;
Eick, Renato George;
Dantas, Gustavo Coelho;
Tino, Michele Káren dos Santos;
Holanda, Maria Izabel de;
Brazil), the Brazilian Thrombotic Microangiopathy and Atypical Hemolytic Uremic Syndrome Study Group (aHUS

Publication type:

Article

Eculizumab, SARS-CoV-2 and atypical hemolytic uremic syndrome.

Published in:

Clinical Kidney Journal, 2020, v. 13, n. 5, p. 739, doi. 10.1093/ckj/sfaa166

By:

Trimarchi, Hernán;
Gianserra, Raquel;
Lampo, Mauro;
Monkowski, Matias;
Lodolo, Jimena

Publication type:

Article

Aliskiren and the dual complement inhibition concept.

Published in:

Clinical Kidney Journal, 2020, v. 13, n. 1, p. 35, doi. 10.1093/ckj/sfz142

By:

Perez-Gomez, Maria Vanessa;
Ortiz, Alberto

Publication type:

Article

Thrombotic microangiopathy induced by interferon beta in patients with multiple sclerosis: three cases treated with eculizumab.

Published in:

Clinical Kidney Journal, 2017, v. 10, n. 5, p. 625, doi. 10.1093/ckj/sfw143

By:

Allinovi, Marco;
Cirami, Calogero Lino;
Caroti, Leonardo;
Antognoli, Giulia;
Farsetti, Silvia;
Amato, Maria Pia;
Minetti, Enrico Eugenio

Publication type:

Article

Should eculizumab be discontinued in patients with atypical hemolytic uremic syndrome?

Published in:

Clinical Kidney Journal, 2017, v. 10, n. 3, p. 320, doi. 10.1093/ckj/sfx024

By:

Rodriguez, Eva;
Barrios, Clara;
Soler, Maria José

Publication type:

Article

Current evidence on the discontinuation of eculizumab in patients with atypical haemolytic uraemic syndrome.

Published in:

Clinical Kidney Journal, 2017, v. 10, n. 3, p. 310, doi. 10.1093/ckj/sfw115

By:

Macia, Manuel;
de Alvaro Moreno, Fernando;
Dutt, Tina;
Fehrman, Ingela;
Hadaya, Karine;
Gasteyger, Christoph;
Heyne, Nils

Publication type:

Article

Novel complement factor H gene mutation causing atypical haemolytic uraemic syndrome: early Eculizumab prevents acute dialysis.

Published in:

Clinical Kidney Journal, 2017, v. 10, n. 2, p. 263, doi. 10.1093/ckj/sfw132

By:

Collett, James;
Mallawaarachchi, Amali;
Fischer, Eddy;
Komala, Muralikrishna Gangadharan;
Sud, Kamal;
Bose, Bhadran

Publication type:

Article

Eculizumab for rescue of thrombotic microangiopathy in PM-Scl antibody-positive autoimmune overlap syndrome.

Published in:

2015

By:

Nester, Carla M.;
Thomas, Christie P.;
Sharma, Manisha;
Lenert, Petar S.;
Phan, Andrew C.;
Steele, Amanda L.

Publication type:

Case Study

Thrombotic microangiopathy: expanding genetic, clinical and therapeutic spectra and the need for worldwide implementation of recent advances.

Published in:

Clinical Kidney Journal, 2015, v. 8, n. 6, p. 686, doi. 10.1093/ckj/sfv115

By:

Sanchez-Niño, Maria D.;
Ortiz, Alberto

Publication type:

Article

Use of eculizumab in crescentic IgA nephropathy: proof of principle and conundrum?

Published in:

Clinical Kidney Journal, 2015, v. 8, n. 5, p. 489, doi. 10.1093/ckj/sfv076

By:

Ring, Troels;
Bang Pedersen, Birgitte;
Salkus, Giedrius;
Goodship, Timothy H. J.

Publication type:

Article

Eculizumab-induced reversal of dialysis-dependent kidney failure from C3 glomerulonephritis.

Published in:

2015

By:

Inman, Melissa;
Prater, Ginnie;
Fatima, Huma;
Wallace, Eric

Publication type:

Case Study

Timing of eculizumab therapy for C3 glomerulonephritis.

Published in:

Clinical Kidney Journal, 2015, v. 8, n. 4, p. 449, doi. 10.1093/ckj/sfv065

By:

Rodriguez-Osorio, Laura;
Ortiz, Alberto

Publication type:

Article

Remission of aHUS neurological damage with eculizumab.

Published in:

Clinical Kidney Journal, 2015, v. 8, n. 2, p. 232, doi. 10.1093/ckj/sfu144

By:

Ávila, Ana;
Vizcaíno, Belén;
Molina, Pablo;
Gavela, Eva;
Perez-Ebri, Maria;
Pallardó, Luís

Publication type:

Article

Eculizumab and drug-induced haemolytic–uraemic syndrome.

Published in:

2013

By:

Faguer, Stanislas;
Huart, Antoine;
Frémeaux-Bacchi, Véronique;
Ribes, David;
Chauveau, Dominique

Publication type:

Case Study

Post-partum atypical haemolytic-uraemic syndrome treated with eculizumab: terminal complement activity assessment in clinical practice.

Published in:

2013

By:

Delmas, Yahsou;
Bordes, Cécile;
Loirat, Chantal;
Frémeaux-Bacchi, Véronique;
Combe, Christian

Publication type:

Case Study